Momenta Pharmaceuticals, Inc (MNTA) Covered Calls

Momenta Pharmaceuticals, Inc. is a biotechnology company with a product pipeline of both complex mixture generic and novel drugs.

You can sell covered calls on Momenta Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MNTA (prices last updated Thu 11:25 AM ET):

Momenta Pharmaceuticals, Inc (MNTA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
14.41 +0.02 14.40 14.44 54K -5.8 1.4B
Covered Calls For Momenta Pharmaceuticals, Inc (MNTA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
May 17 14 0.90 13.54 3.4% 54.0%
Jun 21 14 1.35 13.09 7.0% 44.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Momenta Pharmaceuticals, Inc. is a biotechnology company, engages in the structural analysis of complex mixture drugs. The company focuses on discovering and developing medicines in three product areas: complex generics, biosimilars and novel therapeutics for oncology and autoimmune disease. The three product areas correspond with their respective regulatory pathways. the Company views its business as one reportable operating segment-the discovery, development and commercialization of pharmaceutical products. Momenta Pharmaceuticals was founded by Ram Sasisekharan and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.